Tuesday, May 21
|
||
| Time | Session Title | Speakers |
| 8:55 – 9:00 AM |
Introduction/Housekeeping |
Allison Schmitt, BCLT |
| 9:00 – 10:00 AM |
Impacts of AI’s Rapid Rise in the Life Sciences |
Michelle Chen, In Silico |
| 10:05 – 11:00 AM |
Licensing and Deals Update: Universities and Private Parties |
Ryan Daniel, Fresenius Kabi |
| 11:00 – 11:15 AM |
Break |
|
| 11:15 – 11:55 AM |
Life Sciences Funding Models and Mechanisms |
Paul Billings, Biological Dynamics |
| 12:00 – 12:50 PM |
Amgen One Year Out: What Have We Learned? |
Doug Behrens, Covington
|
| 12:50-1:20 |
Lunch Break |
|
| 1:20 – 2:10 PM |
Obviousness-Type Double Patenting post-Cellect: Strategies and Best Practices |
Gabrielle LaHatte, Latham
|
| 2:10 – 3:15 PM |
Anti-Counterfeiting & Patient Safety |
Lori Mayall, Gilead |
Wednesday, May 22
|
||
| Time | Session Title | Speakers |
| 8:55 – 9:00 AM |
Introduction/Housekeeping |
Allison Schmitt, Berkeley Center for Law & Technology |
| 9:00 – 10:25 AM |
Interplay of Patent and Regulatory Exclusivity: National and Global Considerations |
Kurt Karst, Hyman, Phelps & McNamara |
| 10:25 – 10:40 AM | Break | |
| 10:40 AM – 12:05 PM |
Future Pandemic Preparedness: Use of IP and Data |
Allison Schmitt, BCLT Richard Wilder, Georgetown/UNH |
| 12:05 – 12:20 PM |
Break |
|
| 12:20 -1:15 PM |
Trade Secrets v. Patents |
Gargi Talukder, Orrick |